Continuous Glucose Monitoring Dominates Diabetes Management Market

Author: Dr Nadia Tsao, Research Director at IDTechEx

?

Diabetes is a lifelong condition that requires people to carefully monitor and manage their blood glucose using a range of medical devices. With over 800 million people with diabetes in the world today, the market for diabetes management is substantial. IDTechEx forecasts the market for diabetes management technologies to exceed US$44 billion by 2035, with continuous glucose monitors (CGM) and insulin pump markets driving growth in the next ten years. ??

IDTechEx has recently published the market research report “Diabetes Management Technologies 2025-2035: Markets, Players, and Forecasts”, covering the landscape of medical devices for diabetes management. The report includes discussion and analysis of the key markets of electrochemical glucose test strips, continuous glucose monitors, insulin pens, and insulin pumps. The report also provides an overview of emerging and specialist technologies, including non-invasive glucose monitoring, non-invasive insulin delivery, digital health, advanced therapies, and technologies for the monitoring of complications. The report also forecasts the market opportunity for key diabetes devices over the next ten years to 2035.??

The most impactful technological development in the diabetes market over the past decade has been the continuous glucose monitor (CGM), which has enabled a shift away from electrochemical glucose test strips. By wearing a small electronic skin patch, people with diabetes can continuously monitor their blood glucose levels rather than prick their fingers multiple times a day to draw blood for readings. The benefits for people with diabetes are profound and evidenced by its rapid adoption and the industry’s greater than 30% CAGR over the past ten years.?

The IDTechEx report examines all glucose sensing technologies, including coverage of key glucose sensing enzymes, commercial electrochemical test strip technologies, and compares key metrics of commercial CGMs. The report also explores future technologies in non-invasive glucose monitoring, with an overview of the wide range of technologies developed and their progress toward commercialization.

The electronic skin patch form factor has also seen success in delivering insulin. IDTechEx’s report tracks the success of the insulin patch pump, which has disrupted the insulin delivery market with not only its new form factor but also a new business model. The IDTechEx report covers the commercial status of insulin delivery devices, including smart insulin pens, insulin pumps, alternative insulin technologies, and automated insulin delivery.?

The key driver going forward for the diabetes market will be the continued development of automated insulin delivery (AID) systems towards closed-loop insulin delivery. Already, AID systems today are advanced enough to automatically deliver basal insulin, handle fluctuations in blood glucose, and require minimal manual input at mealtimes. This has been a substantial upgrade of functionality, and further easing the burden of diabetes management will drive uptake of the technology.?

The glucose sensing and insulin delivery industries are highly interlinked – developments within one industry can cause significant effects on others. In the IDTechEx report, “Diabetes Management Technologies 2025-2035: Markets, Players, and Forecasts”, IDTechEx have analyzed the entire market to produce a cohesive story, tying together developments and future milestones to provide realistic ten-year forecasts of each individual market.

?

To find out more about this new IDTechEx report, including downloadable sample pages, please see www.IDTechEx.com/Diabetes.?

For the full portfolio of healthcare market research available from IDTechEx, please see www.IDTechEx.com/Research/Healthcare.